Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications (Q59810295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

4 February 2021

Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

main subject

endocrinology

0 references

cardiovascular disease

4 references

24 March 2019

20 June 2019

17 June 2019

16 September 2019

1 reference

16 September 2019

2 references

16 September 2019

4 February 2021

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Mariana Floria

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Daniela Maria Tanase

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Claudia Florida Costea

4

object named as

Claudia Florida Costea

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

author name string

Alina Mihaela Leustean

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Anca Sava

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Claudia Cristina Tarniceriu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

language of work or name

English

0 references

publication date

12 November 2018

6 references

24 March 2019

20 June 2019

17 June 2019

16 September 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

4 February 2021

Journal of Diabetes Research

6 references

24 March 2019

20 June 2019

17 June 2019

16 September 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

4 February 2021

2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

page(s)

5205126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 April 2020

copyright license

5 references

24 March 2019

20 June 2019

17 June 2019

16 September 2019

on focus list of Wikimedia project

4 February 2021

ScienceSource

0 references

cites work

Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications

1 reference

12 December 2020

The importance of the gastrointestinal system in the pathogenesis of heart failure

1 reference

12 December 2020

Nitric oxide physiology and pathology

1 reference

12 December 2020

Diabetes and cardiovascular disease in older adults: current status and future directions

1 reference

12 December 2020

Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties

1 reference

12 December 2020

Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective

1 reference

12 December 2020

Type 2 diabetes and gut microbiome: at the intersection of known and unknown

1 reference

12 December 2020

Gut Microbiota and Metabolic Disorders

1 reference

12 December 2020

Gut microorganisms as promising targets for the management of type 2 diabetes

1 reference

12 December 2020

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

1 reference

12 December 2020

Probiotics as Complementary Treatment for Metabolic Disorders

1 reference

12 December 2020

Role of the Gut Microbiome in Obesity and Diabetes Mellitus

1 reference

12 December 2020

Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk

1 reference

12 December 2020

Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism

1 reference

12 December 2020

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota

1 reference

12 December 2020

The gut microbiota and metabolic disease: current understanding and future perspectives

1 reference

12 December 2020

Impact of the gut microbiota on inflammation, obesity, and metabolic disease

1 reference

12 December 2020

Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.

1 reference

12 December 2020

Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.

1 reference

12 December 2020

The gut microbiota: a key regulator of metabolic diseases

1 reference

12 December 2020

Trimethylamine N-Oxide: The Good, the Bad and the Unknown

1 reference

12 December 2020

Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus

1 reference

12 December 2020

The Microbiome and Risk for Obesity and Diabetes

1 reference

12 December 2020

The gut-blood barrier permeability - A new marker in cardiovascular and metabolic diseases?

1 reference

12 December 2020

Gut microbiota and acute coronary syndromes: ready for use in the emergency room?

1 reference

12 December 2020

Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects.

1 reference

12 December 2020

Uncovering the trimethylamine-producing bacteria of the human gut microbiota

1 reference

12 December 2020

Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies

1 reference

12 December 2020

Trimethylamine N-oxide: breathe new life.

1 reference

12 December 2020

Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases

1 reference

12 December 2020

Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.

1 reference

12 December 2020

The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction.

1 reference

12 December 2020

Gut bacteria-derived molecules as mediators and markers in cardiovascular diseases. The role of the gut-blood barrier.

1 reference

12 December 2020

The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease.

1 reference

12 December 2020

Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite.

1 reference

12 December 2020

Heart Failure: The Most Important, Preventable, and Treatable Cardiovascular Complication of Type 2 Diabetes.

1 reference

12 December 2020

Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?

1 reference

12 December 2020

Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.

1 reference

12 December 2020

Gut flora-dependent metabolite Trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress.

1 reference

12 December 2020

Gut microbiota in cardiovascular disease and heart failure.

1 reference

12 December 2020

Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.

1 reference

12 December 2020

The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.

1 reference

12 December 2020

High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats

1 reference

12 December 2020

Gut microbiota derived metabolites in cardiovascular health and disease.

1 reference

12 December 2020

Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial

1 reference

12 December 2020

Gut Microbiome and Cardiovascular Diseases.

1 reference

12 December 2020

Identifiers

DOI

10.1155/2018/5205126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539026%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference